The FDA has posted 6 enforcement recalls from Midmark Corporation since 2025, none of them Class I (most serious). Most recent report: Sep 30, 2026.
A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.
A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.
Firm name as filed with the FDA: “Midmark Corporation”. Related firm entities may file under separate names. Source: U.S. FDA openFDA device enforcement reports. Informational only — verify with the FDA before acting.